Singapore Startup Raises $3M for Synthetic Skin Technology

A Singapore biotech company just secured $3 million to bring lab-grown skin treatment to patients suffering from chronic wounds.

The breakthrough technology could help millions facing painful diabetic ulcers and hard-to-heal wounds.